Search Results - "Emerich, Janusz"

Gemcitabine Plus Carboplatin Compared With Carboplatin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer: An Intergroup Trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG by PFISTERER, Jacobus, PLANTE, Marie, OLBRICHT, Sigrid, LE, Tien, EMERICH, Janusz, KUHN, Walther, BENTLEY, James, JACKISCH, Christian, LÜCK, Hans-Joachim, ROCHON, Justine, ZIMMERMANN, Annamaria Hayden, EISENHAUER, Elizabeth, VERGOTE, Ignace, DU BOIS, Andreas, HIRTE, Hal, LACAVE, Angel J, WAGNER, Uwe, STÄHLE, Anne, STUART, Gavin, KIMMIG, Rainer

“…Most patients with advanced ovarian cancer develop recurrent disease. For those patients who recur at least 6 months after initial therapy, paclitaxel platinum…”
Get full text

Randomized, Phase II, Placebo-Controlled, Double-Blind Study With and Without Enzastaurin in Combination With Paclitaxel and Carboplatin As First-Line Treatment Followed by Maintenance Treatment in Advanced Ovarian Cancer by VERGOTE, Ignace B, CHEKEROV, Radoslav, PEIPEI SHI, SEHOULI, Jalid, AMANT, Frederic, HARTER, Philipp, CASADO, Antonio, EMERICH, Janusz, BAUKNECHT, Thomas, MANSOURI, Kambiz, MYRAND, Scott P, NGUYEN, Tuan S

“…Enzastaurin is an oral serine/threonine kinase inhibitor antitumor agent. Our phase II trial tested the efficacy and safety of enzastaurin added to a standard…”
Get full text

High frequency of BRCA1/2 germline mutations in consecutive ovarian cancer patients in Poland by Brozek, Izabela, Ochman, Karolina, Debniak, Jarosław, Morzuch, Lucyna, Ratajska, Magdalena, Stepnowska, Magdalena, Stukan, Maciej, Emerich, Janusz, Limon, Janusz

“…Abstract Background. We estimated the prevalence of BRCA1/2 germline mutations in consecutive ovarian cancers and correlated the mutation status with…”
Get full text

Major complications following exenteration in cases of pelvic malignancy： A 10-year experience by Wydra, Dariusz, Emerich, Janusz, Sawicki, Sambor, Ciach, Katarzyna, Marciniak, Andrzej

“…AIM： To analyze the major complications after exenteration of gynecological and rectal malignancies. METHODS： Twenty-two patients with gynecological malignancy…”
Get full text

Krukenberg tumor--8 years after surgical treatment of gastric carcinoma by Małgorzata, Januszewska, Janusz, Emerich

“…The aim of the study was to discuss the case of Krukenberg tumor in a patient, eight years after the diagnosis and surgical treatment of gastric carcinoma. We…”
Get full text

Human Papillomavirus Type 16 Status in Cervical Carcinoma Cell DNA Assayed by Multiplex PCR by LUKASZUK, Krzysztof, LISS, Joanna, WOZNIAK, Izabela, EMERICH, Janusz, WOJCIKOWSKI, Czesław

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Twenty-four-hour and conventional blood pressure components and risk of preterm delivery or neonatal complications in gestational hypertension by Liro, Marcin, Gasowski, Jerzy, Wydra, Dariusz, Grodzicki, Tomasz, Emerich, Janusz, Narkiewicz, Krzysztof

“…Gestational hypertension is a recognized risk factor for the development of complications during pregnancy. The present study retrospectively assessed the…”
Get more information

Prevalence and clinical correlations of BRCA1/ BRCA2 unclassified variant carriers among unselected primary ovarian cancer cases – preliminary report by Majdak, Ewa J., De Bock, Geertruida H., Brozek, Izabela, Perkowska, Magdalena, Ochman, Karolina, Debniak, Jaroslaw, Milczek, Tomasz, Cornelisse, Cees J., Jassem, J., Emerich, Janusz, Limon, Janusz, Devilee, Peter

“…The objective of this study was to determine the prevalence of BRCA1 and BRCA2 gene mutations in unselected ovarian cancer patients, and to analyse clinical…”
Get full text

HER2 Amplification Has no Prognostic Value in Sporadic and Hereditary Ovarian Tumours by Brozek, Izabela, Kardaś, Iwona, Ochman, Karolina, Debniak, Jarosław, Stukan, Maciej, Ratajska, Magdalena, Morzuch, Lucyna, Emerich, Janusz, Limon, Janusz

“…Whereas HER2 amplification is a well-known phenomenon in breast tumours, its frequency and clinical importance in ovarian cancer have not been established. The…”
Get full text

Prognostic factors and a value of 2009 FIGO staging system in vulvar cancer by Sznurkowski, Jacek J., Milczek, Tomasz, Emerich, Janusz

“…Objective In 2009, International Federation of Gynecology and Obstetrics (FIGO) modified staging of vulvar cancer—the prognostic significance of the new…”
Get full text

Expression of indoleamine 2,3-dioxygenase predicts shorter survival in patients with vulvar squamous cell carcinoma (vSCC) not influencing on the recruitment of FOXP3-expressing regulatory T cells in cancer nests by Sznurkowski, Jacek J, Żawrocki, Anton, Emerich, Janusz, Sznurkowska, Katarzyna, Biernat, Wojciech

“…Abstract Objective Regulatory T cells (Tregs), and the enzyme indoleamine 2,3-dioxygenase (IDO), have potential regulatory properties for immune escape in…”
Get full text

Prognostic significance of CD4+ and CD8+ T cell infiltration within cancer cell nests in vulvar squamous cell carcinoma by Sznurkowski, Jacek Jan, Zawrocki, Anton, Emerich, Janusz, Biernat, Wojciech

“…The clinicopathological significance of the local spontaneous immune reaction in vulvar squamous cell carcinoma remains unclear. The purpose of this study was…”
Get more information

Expression of human HtrA1, HtrA2, HtrA3 and TGF-β1 genes in primary endometrial cancer by NARKIEWICZ, Joanna, LAPINSKA-SZUMCZYK, Sylwia, ZURAWA-JANICKA, Dorota, SKORKO-GLONEK, Joanna, EMERICH, Janusz, LIPINSKA, Barbara

Get full text

Endometriomas are more frequent on the left side by Sznurkowski, Jacek J, Emerich, Janosz

“…To investigate whether asymmetry exists in the left- and right-distribution of ovarian cystic lesions in women with endometriosis. We evaluated operative…”
Get more information

Maspin overexpression correlates with positive response to primary chemotherapy in ovarian cancer patients by Klasa-Mazurkiewicz, Dagmara, Narkiewicz, Joanna, Milczek, Tomasz, Lipińska, Barbara, Emerich, Janusz

“…Abstract Objective Maspin is a member of the serine protease inhibitor superfamily. Experimental studies revealed that maspin suppresses tumor growth,…”
Get full text

Continuous, daily levonorgestrel/ethinyl estradiol vs. 21-day, cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial by Teichmann, Alexander, Apter, Dan, Emerich, Janusz, Greven, Klaus, Klasa-Mazurkiewicz, Dagmara, Melis, Giambi B, Spaczynski, Marek, Grubb, Gary S, Constantine, Ginger D, Spielmann, Daniele

“…Abstract Background This Phase 3, randomized, open-label, multicenter study conducted at 44 sites in Europe evaluated the safety and efficacy of a continuous,…”
Get full text

Clinical significance of VEGFR-2 and VEGFR-3 expression in ovarian cancer patients by Klasa-Mazurkiewicz, Dagmara, Jarząb, Mirosław, Milczek, Tomasz, Lipińska, Barbara, Emerich, Janusz

“…The vascular endothelial growth factor (VEGF) family and VEGF receptors (VEGFR) play an essential role in angiogenesis and lymphangiogenesis. The aim of this…”
Get full text

Should we consider cancer/testis antigens NY-ESO-1, MAGE-A4 and MAGE-A1 as potential targets for immunotherapy in vulvar squamous cell carcinoma? by Sznurkowski, Jacek J, Żawrocki, Anton, Karczewska, Joanna, Emerich, Janusz, Biernat, Wojciech

Get full text

Insertion of IUD after extrauterine mislocation of the previous one by Lewandowski, Jan, Cieminski, Adam, Emerich, Janusz

“…We present a case report of a 37-year-old woman with accidental finding of two IUDs--one inserted correctly and the other one located in the abdomen…”
Get full text

Characteristic features of recurrences of squamous cell carcinoma of the vulva by Sznurkowski, Jacek J, Emerich, Janusz

“…The objective of this study was to find prognostic factors for the development of recurrences in patients who had undergone surgical treatment of vulvar…”
Get full text